THE OUTCOMES OF PATIENTS TREATED WITH 2ND AND 3RD LINE BIOLOGICAL IN PERIANAL CROHN’S DISEASE (PCD) – A MULTICENTRE PROPENSITY SCORE MATCHED STUDY

Uria Shani  1     Monica State  2     Lucian Negreanu  3     Bogdan Radu Mateescu  3     Ana-Maria Davidoiu  3     Isabel Silva  4     Fernando Magro  4     Charlie W. Lees  5     Nikolas Plevris  5     Xavier Roblin  6     Silvia Castellet  7     Iago González Lama  8     Shanshan Wang  8     CAROLINA ABAD  8     Nicola Imperatore  9     Milan Lukas  10     Gabriela Vojtechova  10     Ohad Regev  11     Shomron Ben-Horin  12     Stephane NANCEY  13     Edoardo Savarino  14     Kamila Stawczyk-Eder  15     Piotr Eder  15     Alexandros Toskas  16     Nikolaos Kamperidis  16     Naila Arebi  16     Bernadett Farkas  17     Klaudia Farkas  17     Barbora Pipek  18, 19     Premysl Falt  19     Konstantinos Karmiris  20     PINELOPI NICOLAOU  20     Marko Brinar  21     Lisa Van-Lierop  22     Manuel Barreiro de Acosta  23     Marta Zaborowka  24     Daniela Pugliese  25     Giuseppe Cuccia  26     Uri Kopylov  12    
1 Department of Internal Medicine B, Sheba Medical Center, Tel Hashomer, Affliated to Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, Tel Aviv, Israel
2 Gastroenterology Department, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, Bucharest, Romania
3 Gastroenterology Department, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
4 Clinical Pharmacology Unit, São João University Hospital Center, Porto, Portugal
5 Edinburgh IBD Unit, University of Edinburgh, Edinburgh, United Kingdom
6 University of St. Etienne Dept. de Gastroenterologie, Saint Etienne, France
7 Servei d'Aparell Digestiu, Hospital de Bellvitge, Barcelona, Spain
8 Inflammatory Bowel Disease Unit, Department of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
9 Gastroenterology and Endoscopy Unit, Santa Maria delle Grazie Hospital, Naples, Italy
10 Inflammatory bowel diseases, ISCARE a.s., Prague, Czechia
11 Joyce & Irving Goldman Medical School, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
12 Department of Gastroenterology, Sheba Medical Center, Tel Hashomer, Affliated to Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
13 Dept. de Gastroenterologie, Lyon-Sud Hospital, ,University Claude Bernard Lyon, Pierre Benite, France
14 Gastroenterology Unit, Azienda Ospedale Università di Padova, Padua, Italy
15 University of Medical Sciences in Poznan Department of Gastroenterology, Poznan, Poland
16 Department of IBD and Wolfson Unit for Endoscopy, St Mark's National Bowel Hospital, London, United Kingdom
17 Department of Internal Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary
18 Digestive Diseases Centre, Hospital AGEL Vitkovice, Ostrava, Czech Republic, Ostrava, Czechia
19 2nd Department of Internal Medicine, Gastroenterology and Geriatrics, University Hospital Olomouc, Faculty of Medicine and Dentistry, Olomouc, Czechia
20 Venizeleio General Hospital, Heraklion, Greece
21 University Hospital Centre Zagreb, Zagreb, Croatia
22 Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton AB, Canada
23 Gastroenterology department, University Hospital of Santiago, Santiago de Compostela, Spain
24 Department of Gastroenterology, The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
25 Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy
26 Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing